Impact of SARS-CoV-2 on Dental Practice: A Comprehensive Narrative Review
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Aim This narrative review examines the impact of SARS-CoV-2 on dental practice, integrating evidence on transmission pathways, infection control, oral manifestations, vaccination, and long-term clinical and operational implications. Materials and Methods A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, and Cochrane Library, covering studies published between 2020 and 2025. Eligible studies addressed viral transmission within dental settings, infection-prevention strategies, clinical presentations, vaccination attitudes, and professional guidelines. Data were synthesized qualitatively and organized thematically to reflect the multidimensional impact of the pandemic. Results SARS-CoV-2 RNA was detected in the saliva of over 90% of infected individuals, while 40–45% of cases remained asymptomatic. The use of extraoral suction systems reduced aerosol contamination by up to 90%, and rubber dam application lowered aerosol generation by 80–99%. Oral manifestations occurred in 45–68% of patients, with dysgeusia being the most prevalent (45%). Vaccination acceptance among dental professionals reached 81%. However, healthcare workers still exhibited a high prevalence of long COVID (78%). Economic data indicated that 97% of dental practices closed except for emergencies during peak pandemic periods, while Croatian studies documented a 30.27% reduction in patient visits. The crisis also accelerated the global adoption of teledentistry for consultation and triage. Conclusions SARS-CoV-2 profoundly affected dental practice. Sustained implementation of infection-control protocols and adequate personal protective equipment remains essential, while persistent oral sequelae, such as taste disorders, require ongoing clinical monitoring. Level of Evidence Level 1 (systematic reviews, metaanalyses, RCTs) Level 2 (cohort studies) Level 3 (casecontrol, case series) Level 4 (expert opinion, guidelines, narrative reviews).